AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
30.15
-0.68 (-2.19%)
At close: Jul 24, 2025, 4:00 PM
30.17
+0.03 (0.08%)
After-hours: Jul 24, 2025, 4:20 PM EDT

Company Description

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.

The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation.

It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula’s to support access for EPi-Sense catheters.

In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel.

The company was incorporated in 2000 and is headquartered in Mason, Ohio.

AtriCure, Inc.
AtriCure logo
CountryUnited States
Founded2000
IPO DateAug 5, 2005
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees1,300
CEOMichael Carrel

Contact Details

Address:
7555 Innovation Way
Mason, Ohio 45040
United States
Phone513 755 4100
Websiteatricure.com

Stock Details

Ticker SymbolATRC
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001323885
CUSIP Number04963C209
ISIN NumberUS04963C2098
Employer ID34-1940305
SIC Code3841

Key Executives

NamePosition
Michael H. CarrelChief Executive Officer, President and Director
Angela L. WirickChief Financial Officer
Douglas J. SeithChief Operating Officer
Karl S. Dahlquist CCEP, J.D.Chief Legal Officer
Justin J. NozneskyChief Marketing and Strategy Officer
Salvatore Privitera J.D.Chief Technical Officer
Dr. Vinayak Doraiswamy Ph.D.Chief Scientific Officer
Valerie Storch-WillhausVice President of Corporate Marketing and Communications

Latest SEC Filings

DateTypeTitle
May 29, 2025SDForm - SD
May 28, 2025144Filing
May 20, 20258-KCurrent Report
May 14, 2025SCHEDULE 13GFiling
May 5, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 202510-QQuarterly Report
Apr 29, 20258-KCurrent Report
Apr 7, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 7, 2025DEF 14AOther definitive proxy statements
Mar 26, 20258-KCurrent Report